(A) Pairwise comparisons of three independent cdc48-3:WT analyses, demonstrating low coefficients of variation between biological replicates. (B) Same as (A), except two independent analyses for each of the ubx∆ mutants are plotted. In these replicates the SILAC labels were switched, hence the negative correlation.
Supplemental Figure 2
Curation of Ub conjugates and overlap with previous screens listed in SCUD.
(A) 2-D plot of protein ratios from the His8 Ub tagged vs untagged control experiment (x-axis) and the WT His8 Ub vs WT His8 Ub control (y-axis). Proteins that were recovered in significantly greater amounts (p-value < 0.05) from the His8 Ub expressing cells in the tagged vs untagged control experiment and whose tagged vs tagged ratios did not differ by significantly greater than 10% (p-value ≥ 0.01) were deemed candidate Ub conjugates. (B) Overlap of Ub conjugates in the SCUD database with those identified in this publication.
Supplemental Figure 3
Changes in the Ub proteome in cdc48-3 mutants.
(A) Box and whisker plot of annotation terms demonstrating a significant enrichment in the Ub proteome for a majority of their identified members in the cdc48-3 mutant relative to WT. Significance is defined as the probability that a 
Supplemental Figure 4
Changes in the Ub proteome in ubx∆ mutants 
Supplemental Figure 5
Orthogonal validation of Mga2 ubiquitin conjugate accumulation. WT, ubx2Δ, and ubx4Δ cells expressing myc Mga2 from a YEplac181 plasmid were grown in YPD at 30°C and native lysates were fractionated on a TUBE2 resin. The input extract and bound fractions were immunoblotted for the myc epitope, Ub, and Dpm1
(input loading control) as indicated.
Supplemental Table 1 (provided as Excel workbook)
List of all protein groups identified in this study with corresponding ratios in each in mutant.
Supplemental File 1
Protein groups file table legend.
Supplemental File 2
MS/MS spectra of proteins in screen identified by a single peptide sequence.
Supplemental Table 2 (provided as Excel workbook)
List of all di-Gly modified lysine sites identified in this study. Modified sites were compared to previous studies and listed if previously identified.
Supplemental File 3
di-Gly lysine sites table legend.
Supplemental File 4
MS/MS spectra of the 67 ubiquitinated peptides.
Supplemental Table 3
Strains used in this study. KANMX, 
, MATa
This study RJD 6148 his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, lys2Δ0, arg4::HYG, 
This study RJD 6149 his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, lys2Δ0, arg4::HYG, ubx2::KANMX, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, lys2Δ0, arg4::HYG, ubx4::KANMX, 
This study RJD 6152 his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, lys2Δ0, arg4::HYG, ubx5::KANMX, 
This study RJD 6153 his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, lys2Δ0, arg4::HYG, ubx6::KANMX, 
This study RJD 6154 his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, lys2Δ0, arg4::HYG, ubx7::KANMX, 
,MATa
This study RJD 6155 his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, lys2Δ0, 
, MATa
This study RJD 6156 his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, lys2Δ0, 
, ubx2::KANMX, MATa
This study RJD 6157 his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, lys2Δ0, 
, ubx4::KANMX, MATa
This study RJD 6158 his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, lys2Δ0, ubx2::KANMX, MATa This study RJD 6159 his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, lys2Δ0, ubx4::KANMX, MATa This study GAL2+, MATalpha J. Huibregtse RJD 6160 his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, lys2Δ0, rsp5::KANMX, MATa N. Shcherbik RJD 6161 his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, lys2Δ0, 
, MATa
This Study RJD 6162 his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, lys2Δ0, ubx2::KANMX, MATa This Study RJD 6163 his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, lys2Δ0, ubx4::KAN, MATa This Study RJD his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, lys2Δ0, MATa RJD 6165 his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, lys2Δ0, ubx2::KAN, MATa This study RJD 6166 his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, lys2Δ0, ubx4::KAN, MATa This study RJD 6167 his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, lys2Δ0, MATa This study RJD 6168 his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, lys2Δ0 , leu2Δ0, met15Δ0, lys2Δ0, MATa This study RJD 6173 his3Δ1, leu2Δ0, met15Δ0, lys2Δ0, MATa This study RJD 6174 his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, lys2Δ0, ubx2::KANMX, 
